Cardiovascular Diseases

The Medical Oncology department at Cliniche Gavazzeni is conducting studies that address acute coronary syndrome and aim to lower the risk of repeat heart attacks, while separate trials evaluate new oral anticoagulants for patients with atrial fibrillation. Additional research explores therapies designed to cut major adverse cardiovascular events in individuals with a history of myocardial infarction.

  • Acute coronary syndrome
  • Atrial fibrillation
  • Cardiovascular event prevention
  • Obesity‑related cardiovascular risk

These investigations are part of the site’s broader effort to improve heart health outcomes for the Bergamo community and beyond.

Neoplasms

A robust portfolio of oncology trials at Cliniche Gavazzeni targets advanced solid tumors, with a focus on hormone‑responsive breast cancer, various forms of lung cancer, and rare lymphomas. The studies compare innovative antibody‑drug conjugates and cellular therapies against standard chemotherapy to extend survival and enhance response rates.

  • Advanced solid tumors
  • Hormone‑positive breast cancer
  • Metastatic non‑small cell lung cancer
  • Small cell lung cancer
  • Mantle cell lymphoma

By testing novel agents, the site contributes to advancing cancer care across multiple disease subtypes.

Nutritional and Metabolic Diseases

The clinic’s metabolic research includes a trial of a peptide‑based therapy aimed at improving cardiovascular safety in patients with obesity. Participants receive the investigational drug to assess its impact on weight reduction and related metabolic parameters, with the goal of lowering heart‑related complications.

  • Obesity management
  • Metabolic syndrome
  • Weight‑related cardiovascular outcomes

These efforts align with broader public‑health strategies to combat the growing burden of metabolic disease in Italy.

Environment and Public Health

Beyond individual disease trials, Cliniche Gavazzeni engages in research that examines how environmental exposures influence cancer incidence and cardiovascular risk. Studies also evaluate community‑based screening programs and health‑care delivery models to improve early detection and treatment accessibility.

  • Environmental risk factors for cancer
  • Public health screening initiatives
  • Health‑care delivery research

This multidisciplinary approach supports the institution’s commitment to population health and preventive medicine.